Genotyped and Single Cyst-derived Human ADPKD Cell Platforms for Industry and Academia
Award amount
$838,880Program and phase
SBIR · Phase IIAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- DISCOVERYBIOMED, INC.
- Proposal award date
- 2017-05-05
- Contract end date
- 2019-04-30
- UEI
- LR7QH452JJ31
- Solicitation number
- PA15-052
- Topic code
- 100
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Broad Spectrum Bitter Taste Antagonists Discovery
- STING Inhibitor Discovery for Rare and Common Autoimmune Diseases
- Bitter Human Taste Bud Epithelial Cell Platforms for Bitter Taste Antagonist Discovery
- Humanized Kidney Cellular Toxicity Platforms
- Humanized Kidney Cellular Toxicity Platforms
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- First-in-class TREM-1 inhibitors for neovascular retinal diseases
- Development of a Novel Biosensor to Accelerate Investigations of the Gut Microbiome
- Magnetic Lipid Nanoprobe Platform for Rapid, Highly-Efficient, and Cost-Effective Isolation of Extracellular Vesicles from Non-Invasive Bodily Fluids
- Scale-up and Manufacturing of STLR-201, an off-the-shelf regenerative therapeutic for Sjogren's syndrome-related dry eye disease
- Integrated assays of single-cell dynamics and molecular phenotype for cell therapy manufacturing
Research funding history
19 SBIR/STTR records share this UEI (2008–2020). Reported award amounts total $11,512,428. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services